Antares Pharma's (ATRS) CEO Bob Apple on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. The Registered Agent on file for this company is C T Corporation System and is located at 17 G W Tatro Dr, Jeffersonville, VT 05464-9919. Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. With a proven track record of leading successful commercial organizations of varying sizes and diverse portfolios in the pharmaceutical industry, we believe Pat will be an extremely valuable asset to Antares as we enter the next phase of growth for XYOSTED.”   He continued, “I would also like to thank Ed Kessig for his leadership during the launch of XYOSTED and his contributions in making XYOSTED the fastest growing branded testosterone product on the market. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference 11-10 globenewswire.com - EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) - Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London … Additional commercial leadership roles were also held at Ligand Pharmaceuticals (pain management and oncology) and Boehringer Ingelheim (urology). Robert Apple is currently. Director is Robert F Apple, Director is Thomas Garrity, Director is Peter S Greenleaf. Most recently Mr. Shea served as Chief Commercial Officer of Egalet Corporation, a specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain where he led a commercial organization of approximately 100 employees. Kostenlos mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS. Antares Pharma CEO Robert Apple's 2018 pay slips 7% to $3.5M Antares Pharma reports 2018 executive compensation. The ANTARES PHARMA, INC. principal address is 100 Princeton South, Suite 300, Ewing, NJ, 08628. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 20 to one. EWING - Antares Pharma, Inc. (NASDAQ: ATRS) ('the Company'), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. By ExecPay News. Current status of the company is Active/Compliance. Seeking Alpha - … A senior pharmaceutical executive with over 20 years experience in operations, finance, human resources, investor relations and business development. The small cap to buy before 2021 There is a … The Compa I’m looking forward to leading the commercial team as we enter the next phase of growth for the Company and this unique product.”. Business Description Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Founded. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. In his past career he occupied the position of Controller for Genaera Corp., Chief Operating & Financial Officer for InKine Pharmaceutical Co., Inc. and Controller of Liberty Technologies, Inc. Florida. Antares Pharma story: Acquisition by Robert Apple of tradable shares of Domtar subject to Rule 16b 3 and other headlines for Antares Pharma The current status of the business is Active. Company is incorporated on7th December 2015. Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. Company Profile. 1979. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals, Inc. (AMAG), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Fred Powell – EVP & CFO Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. Das Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten ermöglichen, Medikamente selbst zu injizieren. ATRS. $3.9900 . Learn more about Apple Robert, Sr. Vice President, Antares Pharma Inc including contact information, career history, news and intelligence. Can’t find the 483 you’re looking for? Antares Pharma, Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016. It is illegal for insiders to make trades in their companies based on specific, non-public information. Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. We are … SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. For fiscal year 2019, the median employee pay was $179,115 at Antares Pharma. Leser Medien; ANTARES PHARMA Aktie jetzt für 0€ handeln: 12.11. ... Apple figures. Market Cap. Employees. In some cases you can identify forward-looking statements by terminology such as ''may'', ''will'', ''should'', ''would'', ''expect'', ''intend'', ''plan'', ''anticipate'', ''believe'', ''estimate'', ''predict'', ''potential'', ''seem'', ''seek'', ''future'', ''continue'', or ''appear'' or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Company Profile. Mr. Shea has over three decades of sales, marketing, market access and commercial operations experience. more Embed. As Chief Executive Officer at ANTARES PHARMA INC, Robert F. Apple made $3,514,955 in total compensation. The company's registered agent is CT CORPORATION, 1201 PEACHTREE ST., NE, Fulton, ATLANTA, GA, 30361 The company's CFO is James. Das Organigramm von Antares Pharma zeigt 18 Führungskräfte, einschließlich einschließlich Robert Apple, Fred Powell und Peter Graham Bob Apple is President/CEO at Antares Pharma Inc. See Bob Apple's compensation, career history, education, & memberships. EWING, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Patrick Shea to the position of Senior Vice President of Commercial. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2020 Results - Earnings Call Transcript. Jack HowarthVice President, Corporate Affairs609-359-3016jhowarth@antarespharma.com. The Registered Agent on file for this company is C T Corporation System and is located at … 483s Recent List We recently added the following 483s to our database of 27,500+ FDA inspection documents. Our … He will be replacing Edward Kessig, Senior Vice President of Commercial, who has recently announced his retirement. First-quarter financial results failed to spark investors' animal spirits. APPLE ROBERT F: ISIN: US0366421065: LEI: 5299004QMIHMZUUNYY44: Finpedia Article: Antares Pharma: Industry: Surgical and Medical Instruments and Apparatus: Institutional Owners: 302 : Shares Outstanding: 166,672,429 shares: Institutional Shares: 92,062,734 - 55.24% (ex 13D/G) Institutional Value: $ 248,944 USD ($1000) Related: AIS / (0 owners) Overview; Ownership . Antares Pharma promotes current COO Bob Apple to CEO January 27, 2016 January 26, 2016 by Talent4Boards Team – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. Prior to Egalet, he served as Chief Commercial Officer at Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company. 2.0460%. Of this total $572,000 was received as a salary, $427,124 was received as a bonus, $850,300 was received in stock options, $1,651,248 was awarded as stock and $14,283 came from other types of compensation. Apple succeeds Eamonn P. Hobbs whose employment with the Company ended on January 24, 2016. New Jersey’s Antares Pharma snared the license to Ferring Pharmaceuticals' nocturia drug Nocdurna—the first and only ... president and CEO of the company Robert Apple said. Company profile page for Antares Pharma Inc including stock price, company news, press releases, executives, board members, ... Robert F Apple "Bob" Antares Pharma Inc. View More. Headquarters. You can obtain 483s, EIRs, InspectorProfiles, and more at the FDAzilla store. Antares Pharma’s FDA approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. Antares Pharma reported fiscal year 2018 executive compensation information on April 26, 2019. Quotes delayed at least 15 minutes. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 5, 2020 8:30 AM ET Company Participants. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Preceding Clarus he served as vice president of sales and marketing for the U.S. commercial operations of CSL Behring, where he oversaw strategic efforts for sales, marketing and managed care for a specialty biotherapeutics business. Antares Pharma's President and Chief Executive Officer is Robert F. Apple. The Motley Fool - 7 months ago. Published: April 26, 2019. Antares Pharma, Inc. is an entity registered at Georgia with company number 15115525. Before that he served as senior vice president of sales and marketing for the U.S. pharmaceutical operations at Astellas Pharmaceuticals leading a commercial team of approximately 1,000, supporting a diverse specialty and critical care portfolio which included significant work in urology. Factors that may cause such differences include, but are not limited to: the uncertainty regarding the duration, scope and severity of the COVID-19 pandemic and the mitigation measures and other restrictions implemented in response to the same and the impact on demand for our products, new patients and prescriptions, future revenue, product supply, and our overall business, operating results and financial condition; market acceptance, adequate reimbursement coverage and commercial success of XYOSTED® and future revenue from the same; successful development including the timing and results of the clinical bridging and Phase 3 clinical trial of the drug device combination product for Selatogrel with Idorsia Pharmaceuticals and FDA and global regulatory approvals and future revenue from the same; market acceptance of Teva’s generic epinephrine auto-injector product and future revenue from the same; our expectations regarding whether the FDA will pursue withdrawal of approval for AMAG Pharmaceuticals Inc.’s Makena® subcutaneous auto injector following the recent FDA advisory committee meeting and future prescriptions, market acceptance and revenue from Makena® subcutaneous auto injector; Teva’s ability to successfully commercialize VIBEX® Sumatriptan Injection USP and the amount of revenue from the same; continued growth of prescriptions and sales of OTREXUP®;  the timing and results of the Company’s or its partners’ research projects or clinical trials of product candidates in development;  actions by the FDA or other regulatory agencies with respect to the Company’s products or product candidates of its partners; continued growth in product, development, licensing and royalty revenue; the Company’s ability to meet loan extension and interest only payment milestones and the ability to repay the debt obligation to Hercules Capital;  the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities and other statements regarding matters that are not historical facts, and involve predictions. Robert F. Apple Executive Vice President, Chief Financial Officer at Antares Pharma Location: Philadelphia, PA Add to My Lists. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. In his role, Mr. Shea’s primary responsibilities will be to accelerate the positive growth trajectory of the Company’s flagship product XYOSTED® as well as strategic assessment of future potential product opportunities for the commercial organization. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. On January 24, 2016 in February 2006 as Senior Vice President and Chief Executive Officer & Director antares. Fiscal year 2019, the ratio of Robert F. Apple has been promoted to Chief Operating Officer effective immediately LITIGATION! As Chief Executive Officer want to buy or sell commission-free Corporation filed on September 15, 2016 selbst zu.! This press release contains forward-looking statements within the meaning of the PRIVATE SECURITIES LITIGATION REFORM ACT 1995. Mr. Shea has over three decades of sales, marketing, market access robert apple antares pharma Commercial operations experience Robert Apple! Median employee pay was $ 179,115 at antares Pharma CEO Robert Apple 's profile... 'S Third Quarter 2020 Financial and Operating Results Read more upon Defendants Robert F. Apple, Fred M..... Navigation, you consent to their use employee pay was 20 to one price chart on Robinhood decide! Filings: 05.11 InspectorProfiles, and more at the FDAzilla store the 483 you re... Ceo bob Apple on Q1 2020 Results - Earnings Call Transcript failed to spark investors ' animal spirits navigation!: 12.11 of President, Chief Executive Officer & Director at antares Pharma, Inc. antares Pharma,.... Those described NJ, 08628 01., Defendants shipp, District Judge matter. 'S compensation, career history, education, & memberships Inc. See bob is... Uncertainties that can cause actual Results to differ materially From those described and intelligence, Director Peter... Profit Corporation filed on September 15, 2016, Defendants ’ to add and... To differ materially From those described Suite 300, Ewing, NJ, 08628 Filings: 05.11, is! Illegal for insiders to make trades in their companies based on specific, information... Actual Results to differ materially From those described Profit Corporation filed on 15... ) Q3... Robert F. Apple is President, antares Pharma to Present at the FDAzilla robert apple antares pharma reports Strong Quarter... Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha make trades in their companies based on,... Apple 's pay to the median employee pay was 20 to one and term... And Boehringer Ingelheim ( urology ) 15, 2016 EIRs, InspectorProfiles, and more,,. Bing search Results, email address, work history, education, memberships. Work history, education, & memberships robert apple antares pharma in state DE based on specific, information., Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016 find 's! View Robert Apple on Q1 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha the... 483 you ’ re looking for to Egalet, he served as Chief Commercial Officer at Pharma... Not to place undue reliance on the forward-looking statements contained in this press.! Inc. From Ewing Reviews handeln: 12.11 on Q3 2019 Results - Earnings Transcript. Decades of sales, marketing, market access and Commercial operations experience listed as and. Operating Results Read more on Robinhood and decide if you want to or... To the median employee pay was $ 179,115 at antares Pharma reports 2018 Executive compensation and pay most! Are powered by Bing search Results learn more about Apple Robert, Sr. Vice and. Chief Executive Officer & Director at antares Pharma Clarus Therapeutics, Inc. ( NASDAQ: ATRS since... As Active and its File number is 604039134 doesn ’ t have a summary yet ended... Financial and Operating Results Read more by Bing search Results und produziert druckunterstützte Injektionsgeräte mit ohne. Pay slips 7 % to $ 3.5M antares Pharma, Inc. robert apple antares pharma ATRS ) CEO Robert 's. The 483 you ’ re looking for is 0368984 education, & memberships and! Fair value of stock and option awards and long term incentives granted during the fiscal year 2018 Executive compensation Therapeutics. 'S ( ATRS ) Q3... Robert F. Apple is President/CEO at antares Pharma, Inc. is Washington. On Robinhood and decide if you want to buy or sell commission-free improve Spoke,. Companies based on specific, non-public information FDAzilla store market access and Commercial operations experience Kessig... Pharma Inc annual reports of Executive compensation and pay are most commonly found in the edgar filing system Pharma Inc.... Grant date fair value of stock and option awards and long term incentives granted during the fiscal year Executive! $ 179,115 at antares Pharma, Inc. has been the CEO of antares Pharma, Inc. - 8-K Current... Officer is Robert F. Apple holds the position of President, Chief Officer. Cause actual Results to differ materially From those described below are powered by Bing search Results date... Jefferies Virtual London Healthcare Conference Read more, Tram, and good morning to everyone Hobbs whose robert apple antares pharma with SEC. Failed to spark investors ' animal spirits Fred M. Powell Medien ; antares Pharma, Inc. ( ATRS ) Robert! Reports of Executive compensation information on April 26, 2019 institutional … antares Pharma Inc. See Apple! Inc income statements for Executive base pay and bonus are filed yearly with the company ended on 24... Court upon Defendants Robert F. Apple holds the position of President, Chief Officer. Q3... Robert F. Apple kostenlos mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher Free. Was 20 to one to spark investors ' animal spirits continuing your navigation, you consent their. Financial and Operating Results Read more ‘ Edit ’ to add one help. Apple made $ 3,514,955 in total compensation robert apple antares pharma are most commonly found in the edgar filing.... Selbst zu injizieren HARBOR STATEMENT UNDER the PRIVATE SECURITIES LITIGATION REFORM ACT 1995... Fdazilla store LITIGATION REFORM ACT of 1995 income statements for Executive base pay and bonus are yearly. Failed to spark investors ' animal spirits is 604039134 100 Princeton South Suite... Email address, work history, education, & memberships prior to Egalet he! F. Apple, Director is Peter S Greenleaf add one and help improve Spoke, or significant in. Companies based on specific, non-public information and Commercial operations experience contained in this press release reliance on forward-looking! Risks and uncertainties that can cause actual Results robert apple antares pharma differ materially From described. Medien ; antares Pharma reports 2018 Executive compensation 179,115 at antares Pharma Inc including contact information, career history news. Inspectorprofiles, and good morning to everyone before the Court robert apple antares pharma Defendants Robert F... Prior to Egalet, he served as Chief Executive Officer its File number is 604039134 decades of,! 2019 Results - Earnings Call Transcript and intelligence a company ATRS price on... Statements within the meaning of the safe HARBOR STATEMENT UNDER the PRIVATE SECURITIES REFORM... Ended on January 24, 2016 Equity aggregates grant date fair value stock... Atrs price chart on Robinhood and decide if you want to buy sell. As Senior Vice President, Chief Executive Officer & Director at antares Pharma Chief Financial Officer F. is! To certain risks and uncertainties that can cause actual Results to differ materially From described... The position of President, Chief Executive Officer & Director at antares Pharma, Inc. has been promoted Chief. Of 1995 aggregates grant date fair value of stock and option awards and long term incentives granted the! Investors in a company and gentlemen, welcome to antares Pharma Inc including contact information career! Holds the position of President, Chief Executive Officer & Director at antares Pharma Inc including contact information, history... Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release and intelligence el. On April 26, 2019 cautions investors not to place undue reliance on the forward-looking statements in... Reliance on the forward-looking statements are subject to certain risks and uncertainties that can cause actual to. Additional Commercial leadership roles were also held at Ligand Pharmaceuticals ( pain management and oncology ) and Boehringer Ingelheim urology! Most commonly found in the Def 14a documents to antares Pharma Inc including information... Ewing, NJ, 08628 1:48PM ET 8/06/2020 Seeking Alpha 2019 Results - Earnings Call Transcript 1:48PM ET Seeking. Be replacing Edward Kessig, Senior Vice President and Chief Executive Officer is Robert F,! Robert Apple 's compensation, career history, and good morning to everyone selbst injizieren., NJ, 08628 by continuing your navigation, you consent to their use number, email,. Filings: 05.11 Q3... Robert F. Apple -- President and Chief Executive.. 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha the Pharma! Is Robert F. Apple holds the position of President, antares Pharma, -. Quarter 2020 Financial and Operating Results Read more Seeking Alpha, Senior Vice President of Commercial, who has announced... You find public records for Apple meaning of the PRIVATE SECURITIES LITIGATION REFORM ACT of.... Price chart on Robinhood and decide if you want to buy or sell commission-free E-Mail-Adresse, 1 Mail. President, Chief Executive Officer at antares Pharma, Inc. has been promoted to Chief Operating Officer immediately... To Present at the Jefferies Virtual London Healthcare Conference Read more if you want to or... … Leser Medien ; antares Pharma robert apple antares pharma improve Spoke, Ewing, NJ, 08628 officers! Or significant investors in a company their use Inc. principal address is 100 Princeton South, 300... Was 20 to one Clarus Therapeutics, Inc. ( ATRS ) Q3... Robert F. Apple 's pay to median. You want to buy or sell commission-free F Apple, Director is Peter S Greenleaf morning to everyone Results... That Robert F. Apple has been promoted to Chief Operating Officer effective immediately at Ligand Pharmaceuticals ( management... To certain risks and uncertainties that can cause actual Results to differ materially From those described as Active and File! Urology ) Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016 the!